Observational study of pimecrolimus 1% cream for prevention of transcutaneous sensitization in children with atopic dermatitis during their first year of life

Observational study of pimecrolimus 1% cream for prevention of transcutaneous sensitization in children with atopic dermatitis during their first year of life

IntroductionEpidermal barrier dysfunction in children with atopic dermatitis can cause transcutaneous sensitization to allergens and allergic diseases. We evaluated the effectiveness of an early-intervention algorithm for atopic dermatitis treatment, utilizing pimecrolimus for long-term maintenance...

Full description

Bibliographic Details
Main Authors: Nikolay N. Murashkin, Leyla S. Namazova-Baranova, Svetlana G. Makarova, Roman A. Ivanov, Stepan G. Grigorev, Dmitri V. Fedorov, Eduard T. Ambarchian, Roman V. Epishev, Alexander I. Materikin, Leonid A. Opryatin, Alena A. Savelova
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Pediatrics
Subjects:
atopic dermatitis
children
sensitization
food allergens
indoor allergens
pimecrolimus
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1102354/full

Similar Items

Similar Items